Vitamin D analogs function by interacting with the VDR, a nuclear receptor that regulates the expression of numerous genes involved in cell cycle control, immune response, and other critical pathways. Upon binding to the VDR, these analogs can modulate the transcription of target genes, thereby influencing cancer cell behavior. This mechanism makes them promising candidates for cancer therapy.
